Sheryl Dai’s practice focuses on venture capital, private equity and mergers and acquisitions matters. She represents a number of renowned venture capital funds in connection with their investment in China and U.S. based biotech, pharmaceutical and IT companies at various stages. She also represents institutional investors in structuring and negotiating their investments in private equity funds.

Download full bio 


  • Source Code Capital Raises $1 Billion Fund 

  • Gaorong Capital Closes Fund V at $1.15 Billion 


  • East China University of Political Science and Law

  • University of Wisconsin-Madison

Admissions & Credentials

New York